Nakagawa, Takayuki

Zoledronate Inhibits Osteoclast Differentiation via Suppressing Vascular Endothelial Growth Factor Receptor 2 Expression. [electronic resource] - Biochemical genetics Jun 2020 - 473-489 p. digital

Publication Type: Journal Article

1573-4927

10.1007/s10528-020-09961-2 doi


Animals
Antibodies, Neutralizing--immunology
Bisphosphonate-Associated Osteonecrosis of the Jaw--metabolism
Blood Donors
CD11b Antigen--metabolism
Cell Differentiation--drug effects
Cells, Cultured
Gene Expression--drug effects
Humans
Leukocytes, Mononuclear--metabolism
Mice
NFATC Transcription Factors--genetics
Osteoclasts--cytology
Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors
Zoledronic Acid--pharmacology